Literature DB >> 32555034

Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.

Rasha Khoury1, Peter S Bernstein, Chelsea Debolt, Joanne Stone, Desmond M Sutton, Lynn L Simpson, Meghana A Limaye, Ashley S Roman, Melissa Fazzari, Christina A Penfield, Lauren Ferrara, Calvin Lambert, Lisa Nathan, Rodney Wright, Angela Bianco, Brian Wagner, Dena Goffman, Cynthia Gyamfi-Bannerman, William E Schweizer, Karina Avila, Bijan Khaksari, Meghan Proehl, Fabiano Heitor, Johanna Monro, David L Keefe, Mary E DʼAlton, Michael Brodman, Sharmila K Makhija, Siobhan M Dolan.   

Abstract

OBJECTIVE: To describe the characteristics and birth outcomes of women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as community spread in New York City was detected in March 2020.
METHODS: We performed a prospective cohort study of pregnant women with laboratory-confirmed SARS-CoV-2 infection who gave birth from March 13 to April 12, 2020, identified at five New York City medical centers. Demographic and clinical data from delivery hospitalization records were collected, and follow-up was completed on April 20, 2020.
RESULTS: Among this cohort (241 women), using evolving criteria for testing, 61.4% of women were asymptomatic for coronavirus disease 2019 (COVID-19) at the time of admission. Throughout the delivery hospitalization, 26.5% of women met World Health Organization criteria for mild COVID-19, 26.1% for severe, and 5% for critical. Cesarean birth was the mode of delivery for 52.4% of women with severe and 91.7% with critical COVID-19. The singleton preterm birth rate was 14.6%. Admission to the intensive care unit was reported for 17 women (7.1%), and nine (3.7%) were intubated during their delivery hospitalization. There were no maternal deaths. Body mass index (BMI) 30 or higher was associated with COVID-19 severity (P=.001). Nearly all newborns tested negative for SARS-CoV-2 infection immediately after birth (97.5%).
CONCLUSION: During the first month of the SARS-CoV-2 outbreak in New York City and with evolving testing criteria, most women with laboratory-confirmed infection admitted for delivery did not have symptoms of COVID-19. Almost one third of women who were asymptomatic on admission became symptomatic during their delivery hospitalization. Obesity was associated with COVID-19 severity. Disease severity was associated with higher rates of cesarean and preterm birth.

Entities:  

Mesh:

Year:  2020        PMID: 32555034     DOI: 10.1097/AOG.0000000000004025

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  49 in total

1.  Changes in Preterm Birth Phenotypes and Stillbirth at 2 Philadelphia Hospitals During the SARS-CoV-2 Pandemic, March-June 2020.

Authors:  Sara C Handley; Anne M Mullin; Michal A Elovitz; Kristin D Gerson; Diana Montoya-Williams; Scott A Lorch; Heather H Burris
Journal:  JAMA       Date:  2021-01-05       Impact factor: 56.272

2.  Obstetric-Neonatal Care during Birth and Postpartum in Symptomatic and Asymptomatic Women Infected with SARS-CoV-2: A Retrospective Multicenter Study.

Authors:  Rafael Vila-Candel; Víctor M González-Chordá; Francisco Javier Soriano-Vidal; Enrique Castro-Sánchez; Noelia Rodríguez-Blanco; Ana Gómez-Seguí; Laura Andreu-Pejó; Cristina Martínez-Porcar; Carmen Rodríguez Gonzálvez; Patricia Torrent-Ramos; Nieves Asensio-Tomás; Yolanda Herraiz-Soler; Ramon Escuriet; Desirée Mena-Tudela
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

3.  Women's Health During the COVID-19 Surge in the Bronx: Reflections from Two OBGYNs on the Flatter Side of the Curve.

Authors:  Antoinette A Danvers; Siobhan M Dolan
Journal:  Matern Child Health J       Date:  2020-09

4.  Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York.

Authors:  Sheela Maru; Uday Patil; Rachel Carroll-Bennett; Aaron Baum; Tracy Bohn-Hemmerdinger; Andrew Ditchik; Michael L Scanlon; Parvathy Krishnan; Kelly Bogaert; Carson Woodbury; Duncan Maru; Lawrence Noble; Randi Wasserman; Barry Brown; Rachel Vreeman; Joseph Masci
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

Review 5.  SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis.

Authors:  Katarzyna Grudlewska-Buda; Natalia Wiktorczyk-Kapischke; Ewa Wałecka-Zacharska; Joanna Kwiecińska-Piróg; Katarzyna Buszko; Kamil Leis; Klaudia Juszczuk; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  J Clin Med       Date:  2021-05-03       Impact factor: 4.241

Review 6.  The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis.

Authors:  Tahereh Raeisi; Hadis Mozaffari; Nazaninzahra Sepehri; Mina Darand; Bahman Razi; Nazila Garousi; Mohammad Alizadeh; Shahab Alizadeh
Journal:  Eat Weight Disord       Date:  2021-07-11       Impact factor: 3.008

7.  Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.

Authors:  Whitney R Bender; Adi Hirshberg; Paulina Coutifaris; Alexandra L Acker; Sindhu K Srinivas
Journal:  Am J Obstet Gynecol MFM       Date:  2020-09-11

Review 8.  Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.

Authors:  David A Schwartz; Denise Morotti
Journal:  Viruses       Date:  2020-11-15       Impact factor: 5.048

9.  A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: Clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity.

Authors:  Zohra S Lassi; Ali Ana; Jai K Das; Rehana A Salam; Zahra A Padhani; Omer Irfan; Zulfiqar A Bhutta
Journal:  J Glob Health       Date:  2021-06-30       Impact factor: 4.413

Review 10.  Is pregnancy an immunological contributor to severe or controlled COVID-19 disease?

Authors:  Nazeeh Hanna; Monica Hanna; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-08-20       Impact factor: 3.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.